005690.KS
Pharmicell Co., Ltd.
KSC · Healthcare · Biotechnology · KR
KRW 10,380.00
−1.61%Margins
Gross margin
44.1%
EBITDA margin
34.6%
EBIT margin
32.4%
Net margin
34.3%
FCF margin
19.2%
32.5%
Return on equity
25.3%
Return on assets
26.1%
Return on invested capital
0.77x
Asset turnover
KRW 41.0B
Cash from operations
KRW 1.1K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026